Table 2. Multivariate Cox’s proportional hazard models (n=62).
| Term | Risk ratio | 95% confidence interval | P value |
|---|---|---|---|
| Age | 0.532 | 0.198–1.428 | 0.210 |
| Gender | 1.083 | 0.490–2.395 | 0.843 |
| Etiology | 1.446 | 0.854–2.449 | 0.170 |
| Background liver pathology | 2.040 | 0.760–5.475 | 0.157 |
| Serum AFP | 0.372 | 0.136–1.018 | 0.054 |
| Tumor size | 1.322 | 0.395–4.425 | 0.650 |
| Intrahepatic metastasis | 3.412 | 0.759–15.328 | 0.109 |
| Vascular invasion | 3.494 | 1.454–8.396 | 0.005 |
| Tumor encapsulation | 1.703 | 0.682–4.256 | 0.254 |
| Early recurrence | 4.408 | 1.897–10.238 | 0.001 |
| TNM stage | 1.950 | 0.876–4.339 | 0.102 |
| HMGB2 | 2.674 | 1.058–6.763 | 0.038 |
Multivariate Cox proportional hazards model were employed to further analyze clinical data. AFP, α-fetoprotein; TNM, tumor, lymph node and metastasis; HMGB2, high mobility group box 2.